The Vuze system is designed for spinal stabilization surgeries in outpatient settings, according to a Jan. 18 news release. It does not use sensors or cameras, instead relying on 2D X-rays. The first patient cases were completed in Israel, and the company expects a U.S. debut in mid-2022.
“VUZE Medical was founded to address a technology gap in guiding short-segment spinal interventions. We are aiming to preserve the advantages of common X-ray guidance while addressing its shortcomings,” CEO David Tolkowsky said in the release. “Rising cost pressures and a growing aversion towards hospitalization in the age of COVID-19 are accelerating a shift of short-segment surgeries from inpatient to outpatient and from outpatient to ambulatory settings. In such settings, reliance on X-ray guidance is particularly high. We believe this will be the greatest opportunity for our system.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
